Loading viewer...
investor_presentation
Format: PDF investor_presentation
2020 half -year results UCB’s resilient product portfolio and UCB’s ability to support all stakeholders during COVID- 19 drive company growth27 July 2020
investor_presentation
Ocean Yield
annual_report
investor_presentation
GlaxoSmithKline
investor_presentation
Downer EDI Limited